Perioperative CGM Accuracy 📊🩸 #sciencefather #researchawards #surgeryeducation #perioperative
🔍 Accuracy of Continuous Glucose Monitoring During Noncardiac Surgery 🩺📊
🔬 Introduction: Bridging the Glucose Monitoring Gap
Hyperglycaemia is a frequent yet often overlooked complication in patients undergoing noncardiac surgery. Outside the critical care unit, perioperative glucose fluctuations frequently go undetected, despite being linked to serious outcomes such as infections and myocardial injury 🦠❤️. With a growing emphasis on real-time health data, the integration of Continuous Glucose Monitoring (CGM) into surgical care is drawing attention from both clinicians and researchers.
This multicentre study set out to assess the accuracy of Dexcom G7 CGM sensors during the perioperative period – starting before surgery, continuing through the procedure, and extending 24 hours postoperatively. The results are promising and point toward a new era in glucose surveillance during surgery. 💡
🧪 Study Design: How It Was Done
A total of 118 patients aged over 50 undergoing noncardiac surgery were enrolled across multiple hospitals. All participants were expected to stay at least 24 hours post-surgery. The study involved placing Dexcom G7 sensors on the upper outer arm to measure real-time glucose levels 🧷📉.
🩸 Reference Glucose Readings: Arterial blood glucose was measured via amperometry and served as the gold standard reference.
🔍 Timepoints Analyzed:
-
Before surgery
-
At the end of surgery
-
24 hours after surgery
By collecting paired data from both CGM and blood samples at each point, the researchers could determine how accurate CGM was during this critical window.
📊 Key Metrics Evaluated
To assess accuracy, the study used multiple standard metrics:
✅ Bias (Mean Difference):
Overall mean difference between CGM and blood glucose was 0.38 mM (95% CI: 0.23–0.53), based on 340 paired readings.
📉 Improved Accuracy Over Time:
-
Before surgery: Bias was 1.08 mM
-
End of surgery: Bias dropped to 0.15 mM
This indicates that CGM accuracy improves over the perioperative course, possibly due to physiological stabilization post-anesthesia 🧘♂️🛌.
📏 Mean Absolute Relative Difference (MARD):
Ranged from 12.0% to 18.3%, comparable to real-world CGM use in ambulatory settings.
📈 Error Grid Analysis:
Crucially, >98% of CGM values fell within acceptable risk zones, supporting their reliability for clinical use.
🤖 Implications for Researchers and Technicians
This study represents one of the first large-scale evaluations of CGM during noncardiac surgery, and its implications are exciting:
🔬 For Clinical Researchers:
-
The data validate CGM as a potential tool for future interventional trials targeting perioperative glucose control.
-
Opens the door to exploring CGM in non-diabetic populations, particularly given the finding that 75% of the cohort were non-diabetic.
🛠️ For Biomedical Technicians and Engineers:
-
CGM sensors maintained accuracy despite physiologic fluctuations, anesthesia effects, and patient positioning during surgery.
-
This suggests that sensor placement (upper arm) and algorithmic smoothing are effective even in high-stress environments like the operating room 🧠💉.
🚀 Future Directions
🔄 Integration of CGM data into electronic health records (EHRs) could allow real-time alerts for clinicians.
📡 Wireless CGM combined with closed-loop insulin delivery systems may one day provide automatic glucose regulation during surgery — a major leap toward precision medicine 🧬.
🧪 Further research could focus on:
-
Longer follow-up (72+ hours)
-
CGM use in cardiac surgeries
-
Outcomes in different glycaemic risk profiles
🧠 Conclusion: A Step Toward Safer Surgeries
This multicentre, blinded study confirms that Dexcom G7 CGM is sufficiently accurate for perioperative glucose monitoring, offering a low-burden, high-yield method to detect and address dysglycaemia in surgical patients 🎯💡.
By extending glucose monitoring beyond the ICU and into regular surgical care, CGM has the potential to reduce complications, shorten hospital stays, and improve outcomes. For researchers and technicians alike, this study is a strong signal that continuous glucose monitoring is ready for prime time in the OR 🔔🏥.
Comments
Post a Comment